429PAfatinib in the first line therapy of EGFR mutation positive adenocarcinoma of lung: Single institute experience
Ye, R-H, Wu, Y-Y, Huang, T-C, Chen, J-H, Dai, M-S, Ho, C-LVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx671.018
Date:
November, 2017
File:
PDF, 59 KB
english, 2017